Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 21,000 shares at $15.16 ($318K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Scheduled sale ($318k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.16 | 6,000 | $91K | 28.6% |
| 2 | $15.16 | 15,000 | $227K | 71.4% |
| Total | $15.16 avg | 21,000 | $318K | 100% |
| Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |
| ADMA | SELL | 2025-09-16 | $581K | — | Filing → |